Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621152 · ClinicalTrials.gov registry record · NA
PRevention of Acute Kidney Injury Initiated With Electronic Surveillance Enhancement
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,266
- Enrollment target
NCT01621152: Completed NA study, sponsored by Mayo Clinic.
NCT01621152 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,266 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01621152, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,266 participants
- Enrollment target
Study Summary
Introduction: Acute kidney injury (AKI) increases mortality, hospital cost, and rate of progression toward end stage kidney disease 1-4. Early diagnosis and management of AKI is known to improve the above mentioned outcomes. Hypothesis: the investigators will design and validate an electronic surveillance tool to screen all the ICU admissions for the earlier, more efficient diagnosis of AKI and as a result improve the outcome of AKI in ICU patients. Methods: the investigators plan to use the patient database, and AKIN (AKI network) definition to design an electronic alert system to allow clinicians discover patients who develop AKI. Then a randomized clinical trial will be conducted to compare earlier intervention (based on Kidney Disease: Improving Global Outcomes \[KDIGO\] guidelines) initiated by AKI sniffer alert to the conventional management provided by primary physician in ICU.
Interventions
- OTHER Conventional management arm
- OTHER AKI sniffer instigated AKI management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,266 participants |
| Start Date | 2012-06 |
| Est. Completion | 2021-10-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621152
The ClinicalTrials.gov registry entry for NCT01621152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional management arm is the first listed.
NCT01621152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01621152 about?
NCT01621152 is a clinical study titled "PRevention of Acute Kidney Injury Initiated With Electronic Surveillance Enhancement". Introduction: Acute kidney injury (AKI) increases mortality, hospital cost, and rate of progression toward end stage kidney disease 1-4. Early diagnosis and management of AKI is known to improve the above mentioned outcomes. Hypothesis: the investigators will design and validate an electronic surve...
What is the current status of trial NCT01621152?
This trial is currently completed. It is a NA study. The enrollment target is 2,266 participants. The study started on 2012-06. Estimated completion is 2021-10-19.
What interventions are being tested in trial NCT01621152?
The interventions under investigation include: Conventional management arm (OTHER), AKI sniffer instigated AKI management (OTHER).
Who is sponsoring clinical trial NCT01621152?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.